Low serum cholesterol as a risk factor for hemorrhagic stroke in men -A community-based mass screening in Okinawa, Japan-

Japanese Circulation Journal

Volumn 63, Issue 1, 1999, Pages 53-58

  Okumura, Koichiro ^a   Iseki, Kunitoshi ^a   Wakugami, Kiyoshi ^a   Kimura, Yorio ^a   Muratani, Hiromi ^a   Ikemiya, Yoshiharu ^b   Fukiyama, Koshiro ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b Okinawa Gen Hlth Maintenance A   (Japan)

Author keywords

Cerebral hemorrhage; Cerebral infarction; Serum cholesterol; Stroke

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; RISK FACTOR; STROKE; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CEREBRAL HEMORRHAGE; CEREBROVASCULAR DISORDERS; CHOLESTEROL; FEMALE; HUMANS; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; RISK FACTORS;

EID: 0032904764     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.63.53     Document Type: Article

References (40)

1. Kannel WB, Castelli WP, Gordon T: Cholesterol in the prediction of atherosclerosis disease: New prospect based on the Framingham study. Ann Intern Med 1979; 90: 85-91
2. Tyroler HA: Review of lipid-lowering clinical tries in relation 10 observational epidemiologic studies. Circulation 1987; 76: 515-522
3. Dyker AG, Weir CJ, Lees KR: Influence of cholesterol on survival after stroke: retrospective study. BMJ 1997; 314: 1584-1588
4. Hebert PR. Gaziano JM. Hennekens CH: An overview of trials of cholesterol lowering and risk of stroke. Arch Intern Med 1995; 155: 50-55
5. Statistical and Information Department, Minister's Secretarial. Ministry of Health and Welfare: Health and welfare statistics in Japan. Tokyo: Health and Welfare Statistics Association. 1993
6. Health and Welfare Statistics Association: Health service in Japan: Incidence of health and welfare. Japan: 1992; 39: (in Japanese)
7. Iseki K, Iseki C, Ikemiya Y, Fukiyama K: Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996; 49: 800-805
8. Iseki K, Ikemiya Y, Fukiyama K: Blood pressure and risk of end-stage renal disease in a screened cohort. Kidney Int 1996: (Suppl 55): S69-S71
9. Iseki K. Ikemiya Y. Fukiyama K: Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int 1997; 51: 850-854
10. Wakugami K, Iseki K, Kimura Y, Okumura K, Ikemiya Y, Muratani H, et al: Relationship between serum cholesterol and the risk of acute myocardial infarction in a screened cohort in Okinawa. Japan. Jpn Circ J 1998; 62: 7-14
11. Iseki K, Ikemiya Y, Fukiyama K: Serum cholesterol and risk of end-stage renal disease in cohort of mass screening. Clin Exp Nephrol 1998 (in press)
12. Kinjo K, Kimura Y, Shinzato Y Tomori M, Komine Y, Kawazoe N, et al, and COSMO Group: An epidemiological analysis of cardiovascular disease in Okinawa Japan. Hypertens Res 1992; 15: 111-119
13. Hatano S: Experience from a multicenter stroke register: a preliminary report. Bull WHO 1976; 54: 541-553
14. 63A-1 Study Group on the Registration/ Management/ Follow-up System of Circulatory Disease Patients: The guidelines for registration/ follow-up of cerebrovascular disease patients. 1988 (in Japanese)
15. Tazaki Y: Topics of cerebrovascular disturbance. Medicina 1984; 21: 1897-1899 (in Japanese)
16. SAS/STAT: User's guide, Release 6.03 Edition. Cary, NC: SAS Institute Inc, 1988
17. Tanaka H, Ueda Y, Date C, Baba T, Yamashita H, Hayashi M, et al: Incidence of stroke in Shibata, Japan, 1976-1978. Stroke 1981; 12: 460-466
18. Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD, for the MRFIT Research Group: Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for The Multiple Risk Factor Intervention Trial. N Engl J Med 1989; 320: 904-910
19. Blauw GJ, Lagaay AM, Smelt AH, Westendorp RG: Stroke, statins, and cholesterol: A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke 1997; 28: 946-950
20. Crouse JR III, Byington RP, Hoen HM, Furberg CD: Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med 1997; 157: 1305-1310
21. Iseki K, Miyasato F, Oura T, Uehara H, Nishime K, Fukiyama K: An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis 1994; 23: 547-554
22. Shimamoto T, Komachi Y, Inada H, Doi M, Iso H, Sato S, et al: Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989; 79: 503-515
23. Szatrowski TP, Peterson AV Jr, Shimizu Y, Prentice RL, Mason MW, Fukunaga Y. et al: Serum cholesterol, other risk factors, and cardiovascular disease in a Japanese cohort. J Chronic Dis 1984; 37: 569-584
24. Yamori Y, Horie R, Ikeda K, Nara Y, Lovenberg W: Prophylactic effect of dietary protein on stroke and its mechanism. In: Yamori Y, Lovenberg W, Reis ED, editors. Prophylactic approach to hypertensive disease. New York: Raven Press 1979: 497-504
25. Tanaka H, Ueda Y, Hayashi M, Date C, Baba T, Yamashita H, et al: Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke 1982; 13: 62-73
26. Konishi M, Iso H, Komachi Y, Iida M, Shimamoto T, Jacobs DR, et al: Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries: The Akita Pathology Study. Stroke 1993; 24: 954-964
27. Ueshima H, Iida M, Shimamoto T, Konishi M, Tsujioka K, Tanigaki M, et al: Multivariate analysis of risk factors for stroke: Eight-year follow-up study of farming villages in Akita, Japan. Prev Med 1980; 9: 722-740
28. Wolf PA, Kannel WB, Verter J: Current status of risk factors for stroke. Neurol Clin 1983; 1: 317-343
29. Prospective Studies Collaboration: Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 1995; 346: 1647-1653
30. Tell GS, Crouse JR, Furberg CD: Relation between blood lipids, lipoproteins and cerebrovascular atherosclerosis: A review. Stroke 1988; 19: 423-430
31. Ooneda G, Yoshida Y. Shinkai H, Hori S, Kobori K, Takayama Y, et al: Smooth muscle cells in the development of plasmitic arterionecrosis, arteriosclerosis, and arterial contraction. Blood Vessels 1978; 15: 148-156
32. Yamori Y, Nara Y, Horie R, Ooshima A: Abnormal membrane characteristics of erythrocytes in rat models and men with predisposition to stroke. Clin Exp Hypertens 1980; 6: 1009-1021
33. Kimura N, Nakayama Y, Tashiro H: The 15 year follow-up population survey on cerebrovascular disease in rural Kyushu, Japan. Jpn J Med 1977; 16: 142-144
34. Kimura N, Toshima H, Nakayama Y, Takayama K, Tashiro H, Takagi M: Fifteen-year follow-up population survey on stroke: multivariate analysis of the risk of stroke in farmers of Tanushimaru and fisherman of Ushibuka. In: Katz AAM, editor. Perspectives in cardiovascular research, Vol. 4. Yamori Y, Lovenberg W, Frei ED, editors. Prophylactic approach to hypertensive disease. New York: Raven Press, 1979; 505-510
35. Iseki K, Kinjo K, Kimura Y, Osawa A, Fukiyama K: Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 1993; 44: 1086-1090
36. Marmot MG, Smith GD: Why are the Japanese living longer? BMJ 1989; 299: 1547-1551
37. Blackburn H, Jacobs DR Jr: The ongoing natural experiment of cardiovascular disease in Japan. Circulation 1989; 79: 718-720
38. Omae T, Ueda K: Hypertension and cardiovascular disease: the Japanese experience (Editorial Review). J Hypertens 1988; 6: 343-349
39. Iribarren C, Jacobs DR, Sadler M, Claxton AJ, Sidney S: Low total serum cholesterol and intracerebral hemorrhagic stroke: is the association confined to elderly men? The Kaiser Permanente Medical Care Program. Stroke 1996; 27: 1993-1998
40. Iso H, Naito Y, Kitamura A, Sato S, Kiyama M, Takayama Y, et al: Serum total cholesterol and mortality in a Japanese population. J Clin Epidemiol 1994; 47: 961-969